LIGAND PHARMS GLUCAGON (LGNXZ) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 31 54 sessions, October 16, 2025 to October 20, 2026
- Largest daily move
- +107.7% close of January 15, 2026
- 1-year change
- +114.3% closing prices, October 16, 2025 to October 20, 2026
- 1-month change
- +50% closing prices, September 17, 2026 to October 20, 2026
Company Description
LGNXZ has gained 114.3% over the past year. The last closing price was $0.0030.
For FY2025, LIGAND PHARMS GLUCAGON reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.
This page collects what Stock Titan holds for LGNXZ, including price data, SEC filings, and financial highlights.
Stock Performance
LIGAND PHARMS GLUCAGON (LGNXZ) closed at $0.0030 on October 20, 2026. Over the past 12 months, the price has gained 114.3%.
LGNXZ Metrics & Rankings
Price returns through October 20, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
LIGAND PHARMS GLUCAGON has filed 10 recent SEC filings, including 6 Form 4, 1 Form 144, 1 Form 8-K, 1 Form 8-K/A. The most recent filing was submitted on October 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LGNXZ SEC filings →
Financial Highlights
LIGAND PHARMS GLUCAGON generated $268.1M in revenue in FY2025, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. The current ratio was 22.23, measuring current assets divided by current liabilities.